3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Leukemia, Myeloid, Acute
558
Leukemia
281
Precursor Cell Lymphoblastic Leukemia-Lymphoma
231
Lymphoma
159
Myelodysplastic Syndromes
110
Burkitt Lymphoma
90
Congenital Abnormalities
85
Lymphoma, Non-Hodgkin
84
Leukemia, Monocytic, Acute
83
Leukemia, Myelomonocytic, Acute
81
Lymphoma, Large B-Cell, Diffuse
79
Leukemia, Erythroblastic, Acute
74
Leukemia, Megakaryoblastic, Acute
71
Recurrence
69
Lymphoma, Mantle-Cell
69
Lymphoma, Follicular
48
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Hodgkin Disease
43
Lymphoma, Large-Cell, Immunoblastic
36
Blast Crisis
36
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
32
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, B-Cell, Marginal Zone
23
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Etoposide
7
pegaspargase
5
Methylprednisolone
4
Dexamethasone
4
Cyclophosphamide
3
Alemtuzumab
3
Gemcitabine
2
Emapalumab
2
Doxorubicin
2
zanubrutinib
1
tocilizumab
1
sintilimab
1
ruxolitinib
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Vincristine
1
Thiotepa
1
Tacrolimus
1
Rituximab
1
Prednisone
1
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
1
Methylprednisolone Hemisuccinate
1
Methotrexate
1
Melphalan
1
EPOCH protocol
1
Cytarabine
1
Cisplatin
1
Calcium Dobesilate
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lymphohistiocytosis, Hemophagocytic
×
Cytarabine
×
Clear all
NCT00368355
2020-01-21
MOHEL
Baylor College of Medicine
Phase 2
Completed
46 enrolled
12 charts